Literature DB >> 2568818

Induction of ketone body enzymes in glial cells.

S E Poduslo1.   

Abstract

Ketone bodies serve a dual function in developing brain. They are important sources of energy for metabolism and serve as precursors for lipid synthesis. Astrocytes have two to three times higher activity than oligodendroglia for one of the enzymes involved in ketone body metabolism, 3-ketoacid-CoA transferase. Both glial cell types have similar levels of activity for beta-hydroxybutyrate dehydrogenase. Glucocorticoids and dibutytyl cAMP produce a significant stimulation of activity of both enzymes in astrocytes and oligodendroglia. However, the most striking induction in activity of the two enzymes is in the presence of hydrocortisone and sodium butyrate. There is a three- to eightfold stimulation with these effectors in both astrocytes and oligodendroglia. Thus, in brain the expression of ketone body enzyme activities is finely regulated by hormones and by agents that increase cAMP levels.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2568818     DOI: 10.1016/0003-9861(89)90225-7

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  4 in total

Review 1.  Cerebral metabolic adaptation and ketone metabolism after brain injury.

Authors:  Mayumi L Prins
Journal:  J Cereb Blood Flow Metab       Date:  2007-08-08       Impact factor: 6.200

2.  Simulated microgravity enhances oligodendrocyte mitochondrial function and lipid metabolism.

Authors:  Araceli Espinosa-Jeffrey; Kevin Nguyen; Shalini Kumar; Ochiai Toshimasa; Ryuji Hirose; Karen Reue; Laurent Vergnes; Jason Kinchen; Jean de Vellis
Journal:  J Neurosci Res       Date:  2016-09-28       Impact factor: 4.164

Review 3.  Regulation of Ketone Body Metabolism and the Role of PPARα.

Authors:  Maja Grabacka; Malgorzata Pierzchalska; Matthew Dean; Krzysztof Reiss
Journal:  Int J Mol Sci       Date:  2016-12-13       Impact factor: 5.923

4.  A transition in transcriptional activation by the glucocorticoid and retinoic acid receptors at the tumor stage of dermal fibrosarcoma development.

Authors:  M D Vivanco; R Johnson; P E Galante; D Hanahan; K R Yamamoto
Journal:  EMBO J       Date:  1995-05-15       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.